Extended ischemic times during ex vivo lung perfusion is not associated with increased mortality.
Doug A GouchoeDivyaam SatijaErvin Y CuiAhmed AlyMatthew C HennKukbin ChoiDavid NunleyNahush A MokadamAsvin M GanapathiBryan A WhitsonPublished in: Artificial organs (2024)
If EVLP technology is available, under certain circumstances, surgeons should not be dissuaded from using an allograft with extended ischemic time.
Keyphrases
- ischemia reperfusion injury
- cerebral ischemia
- cardiovascular events
- quality improvement
- contrast enhanced
- risk factors
- magnetic resonance imaging
- cardiovascular disease
- kidney transplantation
- type diabetes
- computed tomography
- magnetic resonance
- coronary artery disease
- thoracic surgery
- subarachnoid hemorrhage
- blood brain barrier